Efficacy and safety of drug-eluting stent implantation for the treatment of in-stent restenosis occurring within bare-metal stent and drug-eluting stent

Journal of Zhejiang University: Science B

Volumn 11, Issue 8, 2010, Pages 553-560

  Ge, Heng ^a   Zhang, Qing ^a   Zhou, Wei ^a   He, Qing ^a   Han, Zhi Hua ^a   He, Ben ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Atherosclerosis; Bare metal stent; Drug eluting stent; In stent restenosis

Indexed keywords

ADULT; ADVERSE OUTCOME; ARTICLE; BARE METAL STENT; BARE METAL STENT IN STENT RESTENOSIS; CONTROLLED STUDY; DRUG ELUTING STENT; DRUG ELUTING STENT IN STENT RESTENOSIS; FEMALE; FOLLOW UP; HUMAN; IMPLANTATION; IN-STENT RESTENOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVASCULARIZATION; SAFETY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SUDDEN DEATH; SURVIVAL;

ADULT; AGED; ANGIOGRAPHY; CORONARY RESTENOSIS; DRUG-ELUTING STENTS; EQUIPMENT DESIGN; FEMALE; HUMANS; MALE; METALS; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; REGRESSION ANALYSIS; RISK; TREATMENT OUTCOME;

EID: 77955490187     PISSN: 16731581     EISSN: 18621783     Source Type: Journal    
DOI: 10.1631/jzus.B1001002     Document Type: Article

References (25)

1. F. Alfonso M.J. Pérez-Vizcayno R. Hernandez A. Bethencourt V. Martí J.R. López-Mínguez J. Angel R. Mantilla C. Morís A. Cequier, et al. 2006 A randomized comparison of sirolimus-eluting stent with balloon angioplasty in patients with in-stent restenosis: results of the restenosis intrastent balloon angioplasty versus elective sirolimus-eluting stenting (RIBS-II) trial Journal of the American College of Cardiology 47 11 2152 2160 10.1016/j.jacc.2005.10.078 1:CAS:528:DC%2BD28Xmt1Kit7w%3D 16750678 (Pubitemid 43795079)
2. H.P. Bestehorn F.J. Neumann H.J. Büttner P. Betz P. Stürzenhofecker E. von Hodenberg A. Verdun L. Levai J.P. Monassier H. Roskamm 2004 Evaluation of the effect of oral verapamil on clinical outcome and angiographic restenosis after percutaneous coronary intervention: the randomized, double-blind, placebo-controlled, multicenter verapamil slow-release for prevention of cardiovascular events after angioplasty (VESPA) Trial Journal of the American College of Cardiology 43 12 2160 2165 10.1016/j.jacc.2004.02. 047 1:CAS:528:DC%2BD2cXmt1Ggurk%3D 15193674 (Pubitemid 38765106)
3. J. Cosgrave G. Melzi S. Corbett G.G. Biondi-Zoccai P. Agostoni R. Babic F. Airoldi A. Chieffo G.M. Sangiorgi M. Montorfano, et al. 2007 Comparable clinical outcomes with paclitaxel- and sirolimus-eluting stents in unrestricted contemporary practice Journal of the American College of Cardiology 49 24 2320 2328 10.1016/j.jacc.2007.02.057 1:CAS:528:DC%2BD2sXmsFKmu7s%3D 17572247 (Pubitemid 46900991)
4. J. Cosgrave G. Melzi S. Corbett G.G. Biondi-Zoccai R. Babic F. Airoldi A. Chieffo G.M. Sangiorgi M. Montorfano I. Michev, et al. 2007 Repeated drug-eluting stent implantation for drug-eluting stent restenosis: the same or a different stent American Heart Journal 153 3 354 359 10.1016/j.ahj.2006.12.009 1:CAS:528:DC%2BD2sXhvVGgsrg%3D 17307411 (Pubitemid 46328767)
5. M. Degertekin E. Regar K. Tanabe P.C. Smits W.J. van der Giessen S.G. Carlier P. de Feyter J. Vos D.P. Foley J.M. Ligthart, et al. 2003 Sirolimus-eluting stent for treatment of complex in-stent restenosis: the first clinical experience Journal of the American College of Cardiology 41 2 184 189 10.1016/S0735-1097(02)02704-3 1:CAS:528:DC%2BD3sXht1Srsrc%3D 12535805 (Pubitemid 36092181)
6. G.R. Dussaillant G.S. Mintz A.D. Pichard K.M. Kent L.F. Satler J.J. Popma S.C. Wong M.B. Leon 1995 Small stent size and intimal hyperplasia contribute to restenosis: a volumetric intravascular ultrasound analysis Journal of the American College of Cardiology 26 3 720 724 10.1016/0735-1097(95)00249-4 1:STN:280:DyaK2MzntVGnsg%3D%3D 7642865
7. S. Garg K. Smith R. Torguson T. Okabe T.L. Slottow D.H. Steinberg P. Roy Z. Xue N. Gevorkian L.F. Satler 2007 Treatment of drug-eluting stent restenosis with the same versus different drug-eluting stent Catheterization and Cardiovascular Interventions 70 1 9 14 10.1002/ccd.21106 17580367 (Pubitemid 47039112)
8. R. Hoffmann G.S. Mintz G.R. Dussaillant J.J. Popma A.D. Pichard L.F. Satler K.M. Kent J. Griffin M.B. Leon 1996 Patterns and mechanisms of in-stent restenosis: a serial intravascular ultrasound study Circulation 94 6 1247 1254 1:STN:280:DyaK28vitVaktQ%3D%3D 8822976
9. D.R. Holmes Jr. P. Teirstein L. Satler M. Sketch J. O'Malley J.J. Popma R.E. Kuntz P.J. Fitzgerald H. Wang E. Caramanica, et al. 2006 Sirolimus-eluting stents vs. vascular brachytherapy for in-stent restenosis within bare-metal stents: the SISR randomized trial The Journal of the American Medical Association 295 11 1264 1273 10.1001/jama.295.11.1264 1:CAS:528: DC%2BD28XisFyrtLs%3D
10. A. Kastrati J. Mehilli J. Dirschinger J. Pache K. Ulm H. Schühlen M. Seyfarth C. Schmitt R. Blasini F.J. Neumann, et al. 2001 Restenosis after coronary placement of various stent types The American Journal of Cardiology 87 1 34 39 10.1016/S0002-9149(00)01268-6 1:STN:280:DC%2BD3M7ksVahsw%3D%3D 11137830 (Pubitemid 32013081)
11. A. Kastrati J. Mehilli N. von Beckerath A. Dibra J. Hausleiter J. Pache H. Schühlen C. Schmitt J. Dirschinger A. Schömig, et al. 2005 Sirolimus-eluting stent or paclitaxel-eluting stent vs. balloon angioplasty for prevention of recurrence in patient with coronary in-stent restenosis: a randomized controlled trial (ISAR-DESIRE) The Journal of the American Medical Association 293 2 165 171 10.1001/jama.293.2.165 1:CAS:528: DC%2BD2MXktVyksw%3D%3D (Pubitemid 40095867)
12. A. Kastrati A. Dibra S. Eberle J. Mehilli J. Suárez de Lezo J.J. Goy K. Ulm A. Schömig 2005 Sirolimuseluting stents vs. paclitaxel-eluting stents in patients with coronary artery disease: meta-analysis of randomized trials The Journal of the American Medical Association 294 7 819 825 10.1001/jama.294.7.819 1:CAS:528:DC%2BD2MXos1Wnsbo%3D (Pubitemid 41175725)
13. R. Kornowski M.K. Hong F.O. Tio O. Bramwell H. Wu M.B. Leon 1998 In-stent restenosis: contributions of inflammatory responses and arterial injury to neointimal hyperplasia Journal of the American College of Cardiology 31 1 224 230 10.1016/S0735-1097(97)00450-6 1:STN:280:DyaK1c%2Fos1SisQ%3D%3D 9426044 (Pubitemid 28064746)
14. F. Liistro M. Fineschi P. Angioli G. Sinicropi G. Falsini T. Gori K. Ducci A. Bravi L. Bolognese 2006 Effectiveness and safety of sirolimus stent implantation for coronary in-stent restenosis: the TRUE (Tuscany registry of sirolimus for unselected in-stent restenosis) Registry Journal of the American College of Cardiology 48 2 270 275 10.1016/j.jacc.2006.03.039 1:CAS:528:DC%2BD28XmvValtL4%3D 16843174
15. R. Mehran G. Dangas A.S. Abizaid G.S. Mintz A.J. Lansky L.F. Satler A.D. Pichard K.M. Kent G.W. Stone M.B. Leon 1999 Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome Circulation 100 18 1872 1878 1:STN:280:DC%2BD3c%2FhsVOqsA%3D%3D 10545431
16. J.W. Moses M.B. Leon J.J. Popma P.J. Fitzgerald D.R. Holmes C. O'shaughnessy R.P. Caputo D.J. Kereiakes D.O. Williams P.S. Teirstein, et al. 2003 Sirolimuseluting stents versus standard stents in patients with stenosis in a native coronary artery The New England Journal of Medicine 349 14 1315 1323 10.1056/NEJMoa035071 1:CAS:528:DC%2BD3sXnvVGitrc%3D 14523139 (Pubitemid 37186209)
17. F.J. Neumann W. Desmet E. Grube J. Brachmann P. Presbitero P. Rubartelli A. Mügge F. Di Pede D. Füllgraf W. Aengevaeren, et al. 2005 Effectiveness and safety of sirolimus-eluting stents in the treatment of restenosis after coronary stent placement Circulation 111 16 2107 2111 10.1161/01.CIR.0000162467.53001.6B 1:CAS:528:DC%2BD2MXjtlKlt7Y%3D 15851617 (Pubitemid 40577906)
18. F. Saia P.A. Lemos C.A. Arampatzis A. Hoye M. Degertekin K. Tanabe G. Sianos P.C. Smits W.J. van der Giessen P.J. de Feyter, et al. 2004 Routine sirolimus eluting stent implantation for unselected in-stent restenosis: insights from the rapamycin eluting stent evaluated at Rotterdam cardiology hospital (RESEARCH) registry Heart 90 10 1183 1188 10.1136/hrt.2003.025536 1:STN:280:DC%2BD2cvlvFSjsw%3D%3D 15367519 (Pubitemid 39279907)
19. G. Sardella R. Colantonio L. de Luca G. Conti A. di Roma M. Mancone E. Canali G. Benedetti F. Fedele 2009 Comparison between balloon angioplasty and additional coronary stent implantation for the treatment of drug-eluting stent restenosis: 18-month clinical outcomes Journal of Cardiovascular Medicine (Hagerstown, Md.) 10 6 469 473
20. J.E. Sousa M.A. Costa A.C. Abizaid B.J. Rensing A.S. Abizaid L.F. Tanajura K. Kozuma G. van Langenhove A.G. Sousa R. Falotico, et al. 2001 Sustained suppression of neointimal proliferation by sirolimus-eluting stents: one-year angiographic and intravascular ultrasound follow-up Circulation 104 17 2007 2011 10.1161/hc4201.098056 1:STN:280:DC%2BD3Mrms12ktQ%3D%3D 11673337
21. J.E. Sousa M.A. Costa A. Abizaid A.G. Sousa F. Feres L.A. Mattos M. Centemero G. Maldonado A.S. Abizaid I. Pinto, et al. 2003 Sirolimus-eluting stent for the treatment of in-stent restenosis: a quantitative coronary angiography and three-dimensional intravascular ultrasound study Circulation 107 1 24 27 10.1161/01.CIR.0000047063.22006.41 1:CAS:528:DC%2BD3sXhs1w%3D 12515737 (Pubitemid 36070927)
22. D.H. Steinberg M.A. Gaglia Jr. T.L. Pinto Slottow P. Roy L. Bonello A. de Labriolle G. Lemesle R. Torguson K. Kineshige Z. Xue, et al. 2009 Outcome differences with the use of drug-eluting stents for the treatment of in-stent restenosis of bare-metal stents versus drugeluting stents The American Journal of Cardiology 103 4 491 495 10.1016/j.amjcard.2008.09.107 1:CAS:528: DC%2BD1MXhs1ert7s%3D 19195508
23. G.W. Stone S.G. Ellis C.D. O'shaughnessy S.L. Martin L. Satler T. McGarry M.A. Turco D.J. Kereiakes L. Kelley J.J. Popma, et al. 2006 Paclitaxel-eluting stents vs. vascular brachytherapy for in-stent restenosis within bare-metal stents: the TAXUS V ISR randomized trial The Journal of the American Medical Association 295 11 1253 1263 10.1001/jama.295.11.1253 1:CAS:528: DC%2BD28XisFyrsbo%3D
24. W.J. van der Giessen A.M. Lincoff R.S. Schwartz H.M. van Beusekom P.W. Serruys D.R. Holmes Jr. S.G. Ellis E.J. Topol 1996 Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries Circulation 94 7 1690 1697 8840862
25. C. Whan Lee S.H. Kim J. Suh D.W. Park S.H. Lee Y.H. Kim M.K. Hong J.J. Kim S.W. Park S.J. Park 2008 Long-term clinical outcomes after sirolimus-eluting stent implantation for treatment of restenosis within bare-metal versus drug-eluting stents Catheterization and Cardiovascular Interventions 71 5 594 598 10.1002/ccd.21399 18311841 (Pubitemid 351550393)